Patents by Inventor Sharon Klepfer

Sharon Klepfer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Canine coronavirus S gene and uses therefor
    Patent number: 6602504
    Abstract: The present invention provides the amino acid and nucleotide sequences of a CCV spike gene, and compositions containing one or more fragments of the spike gene and encoded polypeptide for prophylaxis, diagnostic purposes and treatment of CCV infections.
    Type: Grant
    Filed: October 5, 2001
    Date of Patent: August 5, 2003
    Assignee: Pfizer Inc.
    Inventors: Timothy J. Miller, Sharon Klepfer, Albert Paul Reed, Elaine V. Jones
  • Canine coronavirus S gene and uses therefor
    Publication number: 20020127245
    Abstract: The present invention provides the amino acid and nucleotide sequences of a CCV spike gene, and compositions containing one or more fragments of the spike gene and encoded polypeptide for prophylaxis, diagnostic purposes and treatment of CCV infections.
    Type: Application
    Filed: October 5, 2001
    Publication date: September 12, 2002
    Inventors: Timothy J. Miller, Sharon Klepfer, Albert Paul Reed, Elaine Jones
  • Canine coronavirus S gene and uses therefor
    Patent number: 6372224
    Abstract: The present invention provides the amino acid and nucleotide sequences of a CCV spike gene, and compositions containing one or more fragments of the spike gene and encoded polypeptide for prophylaxis, diagnostic purposes and treatment of CCV infections.
    Type: Grant
    Filed: January 28, 2000
    Date of Patent: April 16, 2002
    Assignee: Pfizer Inc.
    Inventors: Timothy J. Miller, Sharon Klepfer, Albert Paul Reed, Elaine V. Jones
  • Canine coronavirus S gene and uses therefor
    Patent number: 6057436
    Abstract: The present invention provides the amino acid and nucleotide sequences of a CCV spike gene, and compositions containing one or more fragments of the spike gene for prophylaxis, diagnostic, and treatment of CCV infections.
    Type: Grant
    Filed: November 23, 1994
    Date of Patent: May 2, 2000
    Assignee: Pfizer Inc.
    Inventors: Timothy J. Miller, Sharon Klepfer, Albert Paul Reed